Editor's Choice for February 2016

Prof Gordon McVie - ecancer Editor
Editor's Choice for February 2016 ( Prof Gordon McVie - ecancer Editor )
25 Feb 2016

What do healthcare providers think of the iManageCancer project?

Dr Dimitrios Papapaulou – Healthwatch Assistance, Thessalonika, Greece
What do healthcare providers think of the iManageCancer project? ( Dr Dimitrios Papapaulou – Healthwatch Assistance, Thessalonika, Greece )
15 Feb 2016

What do cancer charities think of the iManageCancer project?

Benedikt Geldmacher-Voss - Deutsche Kinderkrebsstiftung, Bonn, Germany
What do cancer charities think of the iManageCancer project? ( Benedikt Geldmacher-Voss - Deutsche Kinderkrebsstiftung, Bonn, Germany )
15 Feb 2016

iManageCancer: Serious games for self-management

Stefan Hoffmann - Serious Games Solutions, Potsdam, Germany
iManageCancer: Serious games for self-management ( Stefan Hoffmann - Serious Games Solutions, Potsdam, Germany )
15 Feb 2016

iManageCancer: Psycho-emotional health and health assessment tools

Prof Gabriella Pravettoni – University of Milan and the European Institute of Oncology, Milan, Italy
iManageCancer: Psycho-emotional health and health assessment tools ( Prof Gabriella Pravettoni – University of Milan and the European Institute of Oncology, Milan, Italy )
15 Feb 2016

iManageCancer: System design and integration

Stephan Kiefer – Fraunhofer Institut Biomedizinische Technik, Sankt Ingbert, Germany
iManageCancer: System design and integration ( Stephan Kiefer – Fraunhofer Institut Biomedizinische Technik, Sankt Ingbert, Germany )
15 Feb 2016

iManageCancer: the Health Avatar Personal Health Record

Prof Feng Dong - University of Bedfordshire, Luton, UK
iManageCancer: the Health Avatar Personal Health Record ( Prof Feng Dong - University of Bedfordshire, Luton, UK )
15 Feb 2016

Editor's choice for January 2016

Prof Gordon McVie - ecancer Editor
Editor's choice for January 2016 ( Prof Gordon McVie - ecancer Editor )
2 Feb 2016

Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
22 Jan 2016

The ManVan: a mobile cancer support service for men with prostate, testicular and penile cancer in Wales

Dr Rachel Iredale -Tenovus Cancer Care, Cardiff, Wales, UK and University of South Wales, Pontypridd, Wales, UK
The ManVan: a mobile cancer support service for men with prostate, testicular and penile cancer in Wales ( Dr Rachel Iredale -Tenovus Cancer Care, Cardiff, Wales, UK and University of South Wales, Pontypridd, Wales, UK )
11 Jan 2016

Entinostat and high-dose Interleukin 2 in renal cell carcinoma patients

Prof Roberto Pili - Indiana University, Indianapolis, USA
Entinostat and high-dose Interleukin 2 in renal cell carcinoma patients ( Prof Roberto Pili - Indiana University, Indianapolis, USA )
9 Jan 2016

Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer

Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )
8 Jan 2016